New On The Block
Cigna CEO Brian Evanko stated that the insurer is exploring strategic options for eviCore, which manages medical claims and reviews prior authorization requests. Cigna also plans to stop selling health insurance plans to individuals starting in 2027, as the company “aims to position Cigna for the future.”
• State Street SPDR S&P 500 ETF Trust stock is approaching key resistance levels. Why is SPY stock breaking out?
Updates From The Block
Sirius XM Holdings Sirius XM (SIRI) is holding preliminary discussions to acquire iHeartMedia iHeartMedia (IHRT). Should the deal go through, it would merge the largest satellite radio provider and the largest radio station owner in America. Apollo Global Management Apollo Global Management (APO) and Irving Azoff are involved in the potential deal process.
Stonepeak and Bernhard Capital Partners have acquired Cleco Group from a consortium of Macquarie Asset Management, British Columbia Investment Management and Manulife Investment Management. The deal values Cleco at approximately $5.75 to $6 billion, sources told Bloomberg.
German media conglomerate Bertelsmann SE has reached an agreement to acquire independent music company Concord. Bertelsmann will combine Concord with its BMG Rights Management division, creating one of the "world's largest music enterprises." While the terms of the acquisition were not disclosed, a source told Bloomberg the newly formed company is valued at approximately $14 billion.
Eli Lilly & Co. Eli Lilly (LLY) has acquired artificial intelligence startup Profluent Inc. in a deal worth up to $2.25 billion. The deal will give Eli Lilly the exclusive rights to new medicines that the AI company develops using DNA editing tools.
Lazard Inc Lazard (LAZ) has bought London-based private markets advisor Campbell Lutyens. The deal, valued at up to $660 million, includes $575 million paid at closing, with the remaining amount due two years later, Bloomberg reported.
KKR & Co. KKR (KKR) announced it is working with investment bankers to explore a $10 billion sale of Flora Food Group. The private equity firm previously tried to offload Flora in 2024 to an Abu Dhabi sovereign wealth fund, but the deal collapsed over a pricing dispute.
Sun Pharmaceutical Industries and Organon & Co. Organon (OGN) announced they have entered into a definitive agreement under which Sun Pharmaceutical will acquire all outstanding shares of Organon for $14 per share in an all‑cash transaction with a valuation of $11.75 billion, a press release stated. The transaction is expected to close early next year, subject to stockholder and regulatory approval.
Chiesi Group will acquire KalVista Pharmaceuticals KalVista Pharmaceuticals (KALV) for a total cash value of approximately $1.9 billion. Under the terms of the merger, Chiesi will be adding Ekterly, the first oral treatment of hereditary angioedema, to its portfolio. The deal was unanimously approved by both Chiesi's and KalVista's boards of directors and is expected to close in the third quarter, pending regulatory approvals.
Hedge fund ADW Capital is considering a $3 billion deal to purchase Driven Brands from private equity firm Roark Capital for $18 per share in cash. ADW believes Driven Brands is “materially undervalued due to self-inflicted structural, capital allocational and governance failures,” a letter to Roark stated.
Uber Technologies Uber (UBER) has purchased Hong Kong-based FlyTaxi as part of its expansion plans in the region, Bloomberg reported. FlyTaxi and Uber will both continue their normal operations, and customers will not see any changes as a result of the acquisition. Terms of the deal were not disclosed.













